Daewoong Pharma, Korea's largest drugmaker, has opened a laboratory in Liaoning that is tasked with working 24/7 to develop oral solutions and solid drugs for China. The lab is part of Liaoning Baifeng, a small China pharma that Daewoong acquired last year. Daewoong has also established corporate offices in Beijing. The company's goal is to achieve $463 million of China revenues in 2020, which it hopes to accomplish through active partnering with local pharmas and academic institutions.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
